Home General Biotechnology Drug Patent Expirations in April 2013

Drug Patent Expirations in April 2013

Drug Patent Expirations for April 2013

TradenameApplicantGeneric NamePatent NumberPatent Expiration
BROVANASunovionarformoterol tartrate6,589,508Apr 3, 2013
RAPLONOrganon Usa Incrapacuronium bromide5,418,226Apr 14, 2013
ACUTECTCis Bio Intl Satechnetium tc-99m apcitide5,508,020Apr 16, 2013
NICODERM CQSanofi Aventis Usnicotine5,508,038Apr 16, 2013
GENOTROPIN PRESERVATIVE FREEPharmacia And Upjohnsomatropin recombinant5,501,673Apr 16, 2013
OXYCONTINPurdue Pharma Lpoxycodone hydrochloride5,508,042Apr 16, 2013
CAVERJECT IMPULSEPharmacia And Upjohnalprostadil5,501,673Apr 16, 2013
GENOTROPIN PRESERVATIVE FREEPharmacia And Upjohnsomatropin recombinant5,435,076Apr 16, 2013
AZOPTAlcon Pharms Ltdbrinzolamide5,461,081*PEDApr 24, 2013
ZELNORMNovartistegaserod maleate5,510,353Apr 26, 2013
HYTRINAbbottterazosin hydrochloride5,412,095Apr 29, 2013
HYTRINAbbottterazosin hydrochloride5,294,615Apr 29, 2013
ALVESCOTakeda Gmbhciclesonide6,036,942Apr 30, 2013
CEDAXPernix Therapceftibuten dihydrate5,599,557Apr 30, 2013
ZETONNATakeda Gmbhciclesonide6,036,942Apr 30, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.